Home › Asset managers › Delaware/Macquarie › 2025-2026 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Delaware/Macquarie voted AGAINST or withheld on, and a shareholder proposal it voted FOR. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
704 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Delaware/Macquarie voted | Funds |
|---|---|---|---|---|---|---|
| TIM SA | 2026-03-31 | Ratify Denisio Augusto Liberato Delfino as Independent Director and Camillo Greco as Director | Director Elections | Board | AGAINST | 2 |
| TURKCELL Iletisim Hizmetleri AS | 2026-05-07 | Appoint Auditor for Sustainability Reporting | Audit-related | Board | AGAINST | 2 |
| TURKCELL Iletisim Hizmetleri AS | 2026-05-07 | Approve Director Remuneration | Compensation | Board | AGAINST | 2 |
| TURKCELL Iletisim Hizmetleri AS | 2026-05-07 | Ratify Director Appointments and Elect Directors | Director Elections | Board | AGAINST | 2 |
| TURKCELL Iletisim Hizmetleri AS | 2026-05-07 | Ratify External Auditors | Audit-related | Board | AGAINST | 2 |
| Tecnoglass Inc. | 2025-12-19 | Advisory approval of the compensation for our named executive officers. | Say-on-Pay | Board | AGAINST | 2 |
| Tecnoglass Inc. | 2025-12-19 | Election of the following Class C directors: Jon Paul "JP" Perez | Director Elections | Board | AGAINST | 2 |
| Tecnoglass Inc. | 2026-06-16 | To elect three Class A directors to serve for the ensuing three-year period until their successors are elected and qualified: Anne Louise Carricarte | Director Elections | Board | AGAINST | 2 |
| Telefonica Brasil SA | 2026-04-16 | Re-Ratify Remuneration of Company's Management and Fiscal Council for 2025 | Compensation | Board | AGAINST | 2 |
| Tencent Holdings Limited | 2026-05-13 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 2 |
| Tencent Holdings Limited | 2026-05-13 | Approve PricewaterhouseCoopers as Auditors and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 2 |
| The Magnum Ice Cream Co. N.V. | 2026-05-07 | Adopt Foundation Plan for Growth | Compensation | Board | AGAINST | 2 |
| The Magnum Ice Cream Co. N.V. | 2026-05-07 | Authorize Board to Exclude Preemptive Rights from Share Issuances | Capital Structure | Board | AGAINST | 2 |
| Tianjin Development Holdings Limited | 2026-06-23 | Approve Deloitte Touche Tohmatsu as Auditors and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 2 |
| Tianjin Development Holdings Limited | 2026-06-23 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 2 |
| Tianjin Development Holdings Limited | 2026-06-23 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 2 |
| TransMedics Group, Inc. | 2026-05-20 | Election of Directors: Edward M. Basile | Director Elections | Board | AGAINST | 2 |
| TransMedics Group, Inc. | 2026-05-20 | To approve an amendment to the TransMedics Group, Inc.'s Amended and Restated 2019 Stock Incentive Plan to increase the maximum aggregate number of shares of common stock that may be issued pursuant to awards granted under the TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan by 2,750,000 shares and make certain other changes as set forth in the proxy statement. | Compensation | Board | AGAINST | 2 |
| Ultragenyx Pharmaceutical Inc. | 2026-05-14 | Approval of the Third Amended and Restated 2023 Incentive Plan. | Compensation | Board | AGAINST | 2 |
| Ultragenyx Pharmaceutical Inc. | 2026-05-14 | Nominees: Daniel G. Welch | Director Elections | Board | ABSTAIN | 2 |
| Uni-President China Holdings Ltd. | 2026-06-05 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 2 |
| Uni-President China Holdings Ltd. | 2026-06-05 | Approve PricewaterhouseCoopers as Auditors and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 2 |
| Uni-President China Holdings Ltd. | 2026-06-05 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 2 |
| Unilever Plc | 2026-05-13 | Authorise Issue of Equity | Capital Structure | Board | AGAINST | 2 |
| Weibo Corporation | 2026-05-27 | Elect Director Charles Guowei Chao | Director Elections | Board | AGAINST | 2 |
| Weibo Corporation | 2026-05-27 | Elect Director Gaofei Wang | Director Elections | Board | AGAINST | 2 |
| Wolters Kluwer NV | 2026-05-21 | Authorize Board to Exclude Preemptive Rights from Share Issuances | Capital Structure | Board | AGAINST | 2 |
| Workiva Inc. | 2026-05-28 | Approval of the Amendment and Restatement of the Workiva Inc. 2014 Equity Incentive Plan to increase the number of shares that may be issued under the Plan. | Compensation | Board | AGAINST | 2 |
| Workiva Inc. | 2026-05-28 | Election of Directors: Michael M. Crow, Ph.D. | Director Elections | Board | ABSTAIN | 2 |
| YETI Holdings, Inc. | 2026-05-07 | Election of four Class II directors: Arne Arens | Director Elections | Board | ABSTAIN | 2 |
| YETI Holdings, Inc. | 2026-05-07 | Election of four Class II directors: Mary Lou Kelley | Director Elections | Board | ABSTAIN | 2 |
| Zee Entertainment Enterprises Limited | 2025-07-10 | Approve Issuance of Fully Convertible Warrants to the Promoter Group Entities on Preferential Basis | Capital Structure | Board | AGAINST | 2 |
| adidas AG | 2026-05-07 | Approve Issuance of Warrants/Bonds with Warrants Attached/Convertible Bonds without Preemptive Rights up to Aggregate Nominal Amount of EUR 4 Billion; Approve Creation of EUR 12.5 Million Pool of Contingent Capital to Guarantee Conversion Rights | Capital Structure | Board | AGAINST | 2 |
| adidas AG | 2026-05-07 | Approve Management Board Remuneration Policy | Compensation | Board | AGAINST | 2 |
| adidas AG | 2026-05-07 | Reelect Ian Gallienne to the Supervisory Board | Director Elections | Board | AGAINST | 2 |
| adidas AG | 2026-05-07 | Reelect Nassef Sawiris to the Supervisory Board | Director Elections | Board | AGAINST | 2 |
| AECOM | 2026-03-03 | Election of Directors: Bradley W. Buss | Director Elections | Board | AGAINST | 1 |
| Abivax SA | 2026-05-11 | Approve Compensation Report | Compensation | Board | AGAINST | 1 |
| Abivax SA | 2026-05-11 | Approve Compensation Report of Corporate Officers | Compensation | Board | AGAINST | 1 |
| Abivax SA | 2026-05-11 | Approve Compensation of Marc de Garidel, CEO | Say-on-Pay | Board | AGAINST | 1 |
| Abivax SA | 2026-05-11 | Approve Compensation of Sylvie Gregoire, Chairwoman of the Board | Say-on-Pay | Board | AGAINST | 1 |
| Abivax SA | 2026-05-11 | Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries, up to Aggregate Nominal Amount of EUR 750,000 | Capital Structure | Board | AGAINST | 1 |
| Abivax SA | 2026-05-11 | Approve Issuance of Equity or Equity-Linked Securities for Qualified Investors, up to Aggregate Nominal Amount of EUR 237,873.56 | Capital Structure | Board | AGAINST | 1 |
| Abivax SA | 2026-05-11 | Approve Issuance of Warrants (Bons) Reserved for Services Providers, Consultants, Employees and Executives, up to 10 Percent of Issued Share Capital | Compensation | Board | AGAINST | 1 |
| Abivax SA | 2026-05-11 | Approve Remuneration Policy of CEO | Compensation | Board | AGAINST | 1 |
| Abivax SA | 2026-05-11 | Approve Remuneration Policy of Chairwoman of the Board | Compensation | Board | AGAINST | 1 |
| Abivax SA | 2026-05-11 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Above | Capital Structure | Board | AGAINST | 1 |
| Abivax SA | 2026-05-11 | Authorize Capital Increase of Up to EUR 750,000 for Future Exchange Offers | Capital Structure | Board | AGAINST | 1 |
| Abivax SA | 2026-05-11 | Authorize Capital Increase of up to 20 Percent of Issued Capital for Contributions in Kind | Capital Structure | Board | AGAINST | 1 |
| Abivax SA | 2026-05-11 | Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 750,000 | Capital Structure | Board | AGAINST | 1 |
| Abivax SA | 2026-05-11 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 750,000 | Capital Structure | Board | AGAINST | 1 |
| Abivax SA | 2026-05-11 | Authorize Repurchase of Up to 10 Percent of Issued Share Capital | Capital Structure | Board | AGAINST | 1 |
| Abivax SA | 2026-05-11 | Authorize up to 10 Percent of Issued Capital for Use in Restricted Stock Plans | Compensation | Board | AGAINST | 1 |
| Abivax SA | 2026-05-11 | Authorize up to 10 Percent of Issued Capital for Use in Stock Option Plans | Compensation | Board | AGAINST | 1 |
| Abivax SA | 2026-05-11 | Reelect June Lee as Director | Director Elections | Board | AGAINST | 1 |
| Abivax SA | 2026-05-11 | Reelect Sylvie Gregoire as Director | Director Elections | Board | AGAINST | 1 |
| Abivax SA | 2026-05-11 | Reelect Troy Ignelzi as Director | Director Elections | Board | AGAINST | 1 |
| Acadia Realty Trust | 2026-05-13 | Election of Trustees: C. David Zoba | Director Elections | Board | AGAINST | 1 |
| Advanced Micro Devices, Inc. | 2026-05-13 | Election of Directors: Abhi Y. Talwalkar | Director Elections | Board | AGAINST | 1 |
| Aena S.M.E. SA | 2026-04-16 | Reelect Maurici Lucena Betriu as Director | Director Elections | Board | AGAINST | 1 |
| AeroVironment, Inc. | 2025-09-25 | To elect the board of directors' four nominees as directors: Charles Thomas Burbage | Director Elections | Board | AGAINST | 1 |
| Aeroports de Paris | 2026-05-21 | Approve Issuance of Equity or Equity-Linked Securities for Private Placements, up to Aggregate Nominal Amount of EUR 29 Million | Capital Structure | Board | AGAINST | 1 |
| Aeroports de Paris | 2026-05-21 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Under Items 19, 20 and 21 | Capital Structure | Board | AGAINST | 1 |
| Aeroports de Paris | 2026-05-21 | Authorize Capital Increase of Up to EUR 29 Million for Future Exchange Offers | Capital Structure | Board | AGAINST | 1 |
| Aeroports de Paris | 2026-05-21 | Authorize Capital Increase of up to 10 Percent of Issued Capital for Contributions in Kind | Capital Structure | Board | AGAINST | 1 |
| Aeroports de Paris | 2026-05-21 | Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 97 Million | Capital Structure | Board | AGAINST | 1 |
| Aeroports de Paris | 2026-05-21 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 29 Million | Capital Structure | Board | AGAINST | 1 |
| Aeroports de Paris | 2026-05-21 | Authorize Repurchase of Up to 10 Percent of Issued Share Capital | Capital Structure | Board | AGAINST | 1 |
| Akamai Technologies, Inc. | 2026-05-13 | Election of Directors: Tom Killalea | Director Elections | Board | AGAINST | 1 |
| Akamai Technologies, Inc. | 2026-05-13 | To approve an amendment to our Second Amended and Restated 2013 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 8,000,000 shares. | Compensation | Board | AGAINST | 1 |
| Akamai Technologies, Inc. | 2026-05-13 | To vote upon a shareholder proposal requiring the Company to provide a report on political spending. | Other Social Issues | Shareholder | FOR | 1 |
| Allogene Therapeutics, Inc. | 2026-06-18 | Election of Directors: Deborah Messemer | Director Elections | Board | ABSTAIN | 1 |
| Allogene Therapeutics, Inc. | 2026-06-18 | Election of Directors: Owen Witte, M.D. | Director Elections | Board | ABSTAIN | 1 |
| Allogene Therapeutics, Inc. | 2026-06-18 | Election of Directors: Vicki Sato, Ph.D. | Director Elections | Board | ABSTAIN | 1 |
| Altimmune, Inc. | 2025-09-25 | Hold an advisory vote on compensation of the Company's named executive officers as disclosed in the attached Proxy Statement. | Say-on-Pay | Board | AGAINST | 1 |
| Amarin Corporation Plc | 2026-05-13 | Ordinary resolution to re-elect Mr. Louis Sterling III as a director. | Director Elections | Board | AGAINST | 1 |
| Ambev SA | 2026-04-30 | Elect Aristoteles Nogueira Filho as Fiscal Council Member and Vasco de Freitas Barcellos Neto as Alternate Appointed by Minority Shareholder | Audit-related | Board | ABSTAIN | 1 |
| Ambev SA | 2026-04-30 | Elect Fabio Colletti Barbosa as Director | Director Elections | Board | AGAINST | 1 |
| Ambev SA | 2026-04-30 | Elect Fernando Mommensohn Tennenbaum as Director | Director Elections | Board | AGAINST | 1 |
| Ambev SA | 2026-04-30 | Elect Fiscal Council Members | Compensation | Board | ABSTAIN | 1 |
| Ambev SA | 2026-04-30 | Elect Lia Machado de Matos as Director | Director Elections | Board | AGAINST | 1 |
| Ambev SA | 2026-04-30 | Elect Michel Dimitrios Doukeris as Director and Ricardo Tadeu Almeida Cabral de Soares as Alternate (Not Linked to Any Specific Director) | Director Elections | Board | AGAINST | 1 |
| Ambev SA | 2026-04-30 | Elect Milton Seligman as Director and David Henrique Galatro de Almeida as Alternate (Not Linked to Any Specific Director) | Director Elections | Board | AGAINST | 1 |
| Ambev SA | 2026-04-30 | Elect Ricardo Manuel Frangatos Pires Moreira as Director | Director Elections | Board | AGAINST | 1 |
| Ambev SA | 2026-04-30 | Elect Victorio Carlos De Marchi as Director | Director Elections | Board | AGAINST | 1 |
| Ambev SA | 2026-04-30 | In Case Cumulative Voting Is Adopted, Do You Wish to Equally Distribute Your Votes Amongst the Nominees? | Director Elections | Board | ABSTAIN | 1 |
| Amcor Plc | 2025-11-06 | Re-election of Directors: Lucrece Foufopoulos-De Ridder | Director Elections | Board | AGAINST | 1 |
| Anglo American Plc | 2025-12-09 | Amend Long-Term Incentive Plan | Compensation | Board | AGAINST | 1 |
| ArcBest Corporation | 2026-04-24 | A shareholder proposal to approve GHG emissions reduction targets, if properly presented at the Annual Meeting. | Environment or Climate | Shareholder | FOR | 1 |
| ArcBest Corporation | 2026-04-24 | To approve the reincorporation of the Company to the State of Texas by conversion. | Extraordinary Transactions | Board | AGAINST | 1 |
| Arcus Biosciences, Inc. | 2026-06-11 | Election of Directors: David Lacey, M.D. | Director Elections | Board | ABSTAIN | 1 |
| Arcus Biosciences, Inc. | 2026-06-11 | Election of Directors: Dietmar Berger, M.D., Ph.D. | Director Elections | Board | ABSTAIN | 1 |
| Arcus Biosciences, Inc. | 2026-06-11 | Election of Directors: Johanna Mercier | Director Elections | Board | ABSTAIN | 1 |
| Arcus Biosciences, Inc. | 2026-06-11 | Election of Directors: Nicole Lambert | Director Elections | Board | ABSTAIN | 1 |
| Ardelyx, Inc. | 2026-06-16 | To approve the amendment to the Amended and Restated 2014 Equity Incentive Award Plan, or the Restated Plan, to increase the maximum number of shares of common stock that may be delivered pursuant to awards granted under the Restated Plan by 9,000,000 shares. | Compensation | Board | AGAINST | 1 |
| Artivion, Inc. | 2026-05-12 | ELECTION OF DIRECTORS: Jeffrey H. Burbank | Director Elections | Board | ABSTAIN | 1 |
| Arvinas, Inc. | 2026-06-24 | Election of two Class II directors: Leslie V. Norwalk, Esq. | Director Elections | Board | ABSTAIN | 1 |
| Associated Banc-Corp | 2026-04-28 | Election of Directors: Eileen A. Kamerick | Director Elections | Board | ABSTAIN | 1 |
| Astera Labs, Inc. | 2026-06-04 | To elect three Class II directors to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Sanjay Gajendra | Director Elections | Board | ABSTAIN | 1 |
| Atea Pharmaceuticals, Inc. | 2026-06-18 | Election of Class III Directors: Barbara Duncan | Director Elections | Board | ABSTAIN | 1 |
← Previous Page 4 of 8 Next →
← Back to Delaware/Macquarie 2025-2026 overview
Built 2026-10-04 from SEC Form N-PX filings.